Revolutionizing Perioperative Hypothermia Management with Remimazolam
The Hidden Dangers of Perioperative Hypothermia
Did you know that perioperative hypothermia, a common complication during general anesthesia, can lead to a host of adverse outcomes? From surgical site infections to coagulopathy and delayed drug metabolism, the consequences are far-reaching. Older patients, with their reduced thermoregulatory capacity and metabolic rate, are especially vulnerable. Procedures like transurethral resection of the bladder (TURB) and prostate (TURP) further increase the risk due to continuous irrigation with large fluid volumes.
Remimazolam's Advantage in Temperature Control
Anaesthetic agents play a crucial role in thermoregulation. While most general anesthetics promote heat redistribution, midazolam and its ultrashort-acting analogue, remimazolam, offer a milder approach. By maintaining vasomotor tone and reducing heat loss, remimazolam ensures a rapid onset and offset, cardiovascular stability, and organ-independent metabolism, making it ideal for older patients. In contrast, volatile anesthetics like sevoflurane may increase susceptibility to perioperative hypothermia due to age-dependent effects.
A Study's Findings: Remimazolam's Superiority
A recent study compared the effects of remimazolam and sevoflurane on intraoperative and postoperative thermoregulation in older patients undergoing TURB or TURP. The results were striking: remimazolam preserved core body temperature more effectively, with a smaller mean intraoperative decrease and fewer episodes of profound hypothermia. Additionally, patients receiving remimazolam required less active warming postoperatively, highlighting its thermoregulatory advantage.
Clinical Implications and Future Directions
Maintaining normothermia during surgery is crucial for reducing complications and enhancing recovery, especially in vulnerable older patients. Remimazolam's favorable thermoregulatory profile may significantly benefit urological procedures and other surgeries with high heat-loss risk. While the study focused on short-duration procedures, further research is needed to explore remimazolam's effects in longer operations and compare it with other intravenous or volatile anesthetics. Implementing remimazolam in clinical practice could revolutionize perioperative outcomes, minimize hypothermia-related risks, and enhance patient safety in older surgical populations.
Optimizing Anaesthetic Choice for Improved Outcomes
By optimizing anesthetic choice, clinicians can better safeguard thermoregulation, leading to improved immediate and longer-term surgical outcomes for older adults. This is a significant step towards enhancing patient safety and minimizing the risks associated with perioperative hypothermia.
Reference and Further Exploration
For more information, refer to the study by Choi et al., titled 'Comparison of remimazolam and sevoflurane on perioperative body temperature changes in older patients undergoing transurethral resection of prostate or bladder tumors under general anesthesia: a randomized prospective clinical trial.' The study is published in Clin Interv Aging (2025;20:1811-20) and is available under the Creative Commons Attribution-Non Commercial 4.0 License.
